Tackling the pillars of ageing to fight COVID-19.
作者信息
Prattichizzo Francesco, Sabbatinelli Jacopo, de Candia Paola, Olivieri Fabiola, Ceriello Antonio
机构信息
IRCCS MultiMedica, Milan 20138, Italy.
Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Italy.
出版信息
Lancet Healthy Longev. 2021 Apr;2(4):e191. doi: 10.1016/S2666-7568(21)00053-2. Epub 2021 Mar 31.
Abstract
摘要
相似文献
1
Tackling the pillars of ageing to fight COVID-19.
Lancet Healthy Longev. 2021 Apr;2(4):e191. doi: 10.1016/S2666-7568(21)00053-2. Epub 2021 Mar 31.
2
Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis.
Lancet Healthy Longev. 2021 Jan;2(1):e34-e41. doi: 10.1016/S2666-7568(20)30033-7. Epub 2020 Dec 3.
3
Response to "Metformin use and risk of COVID-19 among patients with type II diabetes mellitus: an NHIS-COVID-19 database cohort study".
Acta Diabetol. 2022 Jun;59(6):869-870. doi: 10.1007/s00592-022-01861-8. Epub 2022 Mar 4.
4
Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes.
Cell Metab. 2020 Oct 6;32(4):537-547.e3. doi: 10.1016/j.cmet.2020.08.013. Epub 2020 Aug 20.
5
Effects of metformin, insulin on COVID-19 patients with pre-existed type 2 diabetes: A multicentral retrospective study.
Life Sci. 2021 Jun 15;275:119371. doi: 10.1016/j.lfs.2021.119371. Epub 2021 Mar 19.
6
Risk of Metformin in Patients With Type 2 Diabetes With COVID-19: A Preliminary Retrospective Report.
Clin Transl Sci. 2020 Nov;13(6):1055-1059. doi: 10.1111/cts.12897. Epub 2020 Oct 19.
7
Metformin and ageing: improving ageing outcomes beyond glycaemic control.
Diabetologia. 2017 Sep;60(9):1630-1638. doi: 10.1007/s00125-017-4349-5. Epub 2017 Aug 2.
8
Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: A meta-analysis.
J Med Virol. 2021 Feb;93(2):695-697. doi: 10.1002/jmv.26498. Epub 2020 Sep 30.
9
How anti-ageing drugs could boost COVID vaccines in older people.
Nature. 2020 Oct;586(7829):352-354. doi: 10.1038/d41586-020-02856-7.
10
Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis.
Am J Trop Med Hyg. 2020 Jul;103(1):69-72. doi: 10.4269/ajtmh.20-0375. Epub 2020 May 21.
引用本文的文献
1
Effect of Hyperglycemia on COVID-19 Outcomes: Vaccination Efficacy, Disease Severity, and Molecular Mechanisms.
J Clin Med. 2022 Mar 12;11(6):1564. doi: 10.3390/jcm11061564.
2
Association between Hyperglycemia at Hospital Presentation and Hospital Outcomes in COVID-19 Patients with and without Type 2 Diabetes: A Retrospective Cohort Study of Hospitalized Inner-City COVID-19 Patients.
Nutrients. 2021 Jun 26;13(7):2199. doi: 10.3390/nu13072199.
3
Pharmacological management of COVID-19 in type 2 diabetes.
J Diabetes Complications. 2021 Jul;35(7):107927. doi: 10.1016/j.jdiacomp.2021.107927. Epub 2021 Apr 17.
本文引用的文献
1
Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis.
Lancet Healthy Longev. 2021 Jan;2(1):e34-e41. doi: 10.1016/S2666-7568(20)30033-7. Epub 2020 Dec 3.
2
Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes.
Cytokine Growth Factor Rev. 2020 Jun;53:33-37. doi: 10.1016/j.cytogfr.2020.04.005. Epub 2020 May 3.
3
Association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis of cohort studies.
Crit Care. 2019 Feb 18;23(1):50. doi: 10.1186/s13054-019-2346-4.
4
Pleiotropic effects of metformin: Shaping the microbiome to manage type 2 diabetes and postpone ageing.
Ageing Res Rev. 2018 Dec;48:87-98. doi: 10.1016/j.arr.2018.10.003. Epub 2018 Oct 15.
5
Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis.
Ageing Res Rev. 2017 Nov;40:31-44. doi: 10.1016/j.arr.2017.08.003. Epub 2017 Aug 10.
Zotero 插件